antibiotics

First Opinion By Janet Midega

New global data showing 1.27 million deaths a year reveal the urgent need to address antimicrobial resistance

Pharmalot By Ed Silverman

McDonald’s accused of dragging its feet on goal of reducing antibiotic use in beef supplies

Pharmalot By Ed Silverman

A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis finds

First Opinion Podcast By Patrick Skerrett

Listen: An antibiotic expert on her body’s stinging betrayal by these drugs

In the Lab By Peter Andrey Smith

In the hunt for novel antibiotics, will new technology overtake underwater exploration?

Pharma By Ed Silverman

STAT+ Conversations: the revitalization of the antibiotic drug pipeline

Pharma By Ed Silverman

Drug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?

Pharmalot By Ed Silverman

Lawmakers revive legislation to accelerate the development of new antibiotics

Opinions+ By Peter Bak

Investment in antimicrobials was up in 2020, but much work remains

Pharmalot By Ed Silverman

WHO warns the world is still failing to develop desperately needed antibiotics

Pharmalot By Ed Silverman

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

Pharmalot By Ed Silverman

Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed

Pharmalot By Ed Silverman

Antibiotic prescribing during the pandemic raises concern about drug resistance

First Opinion By Michelle McMurry-Heath

The Biden administration’s pandemic agenda must not ignore superbugs

Politics By Matthew Herper

Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria

Health By Matthew Herper and Ed Silverman

Virtual Event: Facing the crisis of drug-resistant germs

Pharmalot By Ed Silverman

Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline

First Opinion By Jowa (Zhuo) Shi and Ateev Mehrotra

Inappropriately prescribed antibiotics will likely accompany the winter surge of Covid-19

Pharmalot By Ed Silverman

New bill would create a subscription payment model to jumpstart antibiotic development

Pharmalot By Ed Silverman

Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem

First Opinion By Kevin Outterson and John Rex

We need new antimicrobials to prevent the next infectious disease crisis

Special Report By Gardiner Harris and Alex W. Palmer — The Wire

China has near-total control of the world’s antibiotic supply. Is America at risk as a result?

First Opinion By Isaac Stoner

Saving lives should be good business. Why doesn’t that apply to finding new antibiotics?

Pharmalot By Ed Silverman

WHO adviser says an antimicrobial fund can help a market that ‘needs to be fixed’

Pharmalot By Ed Silverman

Pharmalittle: France indicts Sanofi over epilepsy drug risks; Trump talk of drug pricing in SOTU speech may backfire